Ichor Biologics is seeking eighty to one hundred million dollars from private equity investors. The Hyderabad-based company operates in the specialized plasmatherapy segment. Promoters Ananda Reddy Sudini and Sujana Sudini hold significant stakes in the firm. Ichor manufactures therapeutic protein products derived from human plasma. The company's products serve various critical therapeutic areas.
RSS News
Economic times
0 thoughts on “Ichor Biologics seeks $80-100 million PE funding for minority stake sale”
Leave a Reply
Your email address will not be published. Required fields are marked *
RECENT NEWS
- 'Historic Milestone': Amit Shah says India secures deportation of narco kingpin Navpreet Singh from Turkey
- Floods in 255 villages of 6 districts of Bihar: 15 rivers in UP above danger mark; Temperature crosses 40°C in Rajasthan
- Asian Games 2026 Day 15 Live Update: Kumkum is playing for gold, facing Korea.
- Shivya Nath's column: The boundaries between the village and the city should be erased beautifully
- When, where and how will you be able to watch the India-Pakistan final live? Know live streaming details
